These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 27917531)

  • 21. Possible association of lower rate of postherpetic neuralgia in patients on anti-tumor necrosis factor-α.
    Javed S; Kamili QU; Mendoza N; Tyring SK
    J Med Virol; 2011 Nov; 83(11):2051-5. PubMed ID: 21915882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand.
    Aunhachoke K; Bussaratid V; Chirachanakul P; Chua-Intra B; Dhitavat J; Jaisathaporn K; Kaewkungwal J; Kampirapap K; Khuhaprema T; Pairayayutakul K; Pitisuttithum P; Sindhvananda J; Thaipisuttikul Y;
    Int J Dermatol; 2011 Apr; 50(4):428-35. PubMed ID: 21413953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study.
    Mizukami A; Sato K; Adachi K; Matthews S; Holl K; Matsuki T; Kaise T; Curran D
    Clin Drug Investig; 2018 Jan; 38(1):29-37. PubMed ID: 29086340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
    Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
    BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes zoster and postherpetic neuralgia.
    Johnson RW
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is peptic ulcer disease a risk factor of postherpetic neuralgia in patients with herpes zoster?
    Chen JY; Chang CY; Lan KM; Sheu MJ; Lu CL; Hu ML
    Med Hypotheses; 2013 Nov; 81(5):834-8. PubMed ID: 24074834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
    Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
    BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
    Cunningham AL; Lal H; Kovac M; Chlibek R; Hwang SJ; Díez-Domingo J; Godeaux O; Levin MJ; McElhaney JE; Puig-Barberà J; Vanden Abeele C; Vesikari T; Watanabe D; Zahaf T; Ahonen A; Athan E; Barba-Gomez JF; Campora L; de Looze F; Downey HJ; Ghesquiere W; Gorfinkel I; Korhonen T; Leung E; McNeil SA; Oostvogels L; Rombo L; Smetana J; Weckx L; Yeo W; Heineman TC;
    N Engl J Med; 2016 Sep; 375(11):1019-32. PubMed ID: 27626517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.
    Honda M; Murata T; Ebata N; Fujii K; Ogawa S
    J Dermatol; 2017 Jul; 44(7):767-773. PubMed ID: 28256737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes zoster and postherpetic neuralgia in Catalonia (Spain).
    Salleras L; Salleras M; Salvador P; Soldevila N; Prat A; Garrido P; Domínguez A
    Hum Vaccin Immunother; 2015; 11(1):178-84. PubMed ID: 25483532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review and meta-analysis of risk factors for postherpetic neuralgia.
    Forbes HJ; Thomas SL; Smeeth L; Clayton T; Farmer R; Bhaskaran K; Langan SM
    Pain; 2016 Jan; 157(1):30-54. PubMed ID: 26218719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.
    Alicino C; Trucchi C; Paganino C; Barberis I; Boccalini S; Martinelli D; Pellizzari B; Bechini A; Orsi A; Bonanni P; Prato R; Iannazzo S; Icardi G
    Hum Vaccin Immunother; 2017 Feb; 13(2):399-404. PubMed ID: 27925843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.
    Kawai K; Rampakakis E; Tsai TF; Cheong HJ; Dhitavat J; Covarrubias AO; Yang L; Cashat-Cruz M; Monsanto H; Johnson K; Sampalis JS; Acosta CJ
    Int J Infect Dis; 2015 May; 34():126-31. PubMed ID: 25841633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.
    Gauthier A; Breuer J; Carrington D; Martin M; Rémy V
    Epidemiol Infect; 2009 Jan; 137(1):38-47. PubMed ID: 18466661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Oxman MN; Levin MJ; Johnson GR; Schmader KE; Straus SE; Gelb LD; Arbeit RD; Simberkoff MS; Gershon AA; Davis LE; Weinberg A; Boardman KD; Williams HM; Zhang JH; Peduzzi PN; Beisel CE; Morrison VA; Guatelli JC; Brooks PA; Kauffman CA; Pachucki CT; Neuzil KM; Betts RF; Wright PF; Griffin MR; Brunell P; Soto NE; Marques AR; Keay SK; Goodman RP; Cotton DJ; Gnann JW; Loutit J; Holodniy M; Keitel WA; Crawford GE; Yeh SS; Lobo Z; Toney JF; Greenberg RN; Keller PM; Harbecke R; Hayward AR; Irwin MR; Kyriakides TC; Chan CY; Chan IS; Wang WW; Annunziato PW; Silber JL;
    N Engl J Med; 2005 Jun; 352(22):2271-84. PubMed ID: 15930418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.
    Yawn BP; Saddier P; Wollan PC; St Sauver JL; Kurland MJ; Sy LS
    Mayo Clin Proc; 2007 Nov; 82(11):1341-9. PubMed ID: 17976353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of Perceived Mental Stress, Sense of Purpose in Life, and Negative Life Events With the Risk of Incident Herpes Zoster and Postherpetic Neuralgia: The SHEZ Study.
    Takao Y; Okuno Y; Mori Y; Asada H; Yamanishi K; Iso H
    Am J Epidemiol; 2018 Feb; 187(2):251-259. PubMed ID: 29036443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes.
    Yen FS; Wei JC; Yip HT; Hsu CC; Hwu CM
    J Med Virol; 2023 Jan; 95(1):e28278. PubMed ID: 36329608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
    Marino MG; Bagnato B; Torella I; Franco E
    Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.